Camac Fund, LP, Insider at Pasithea Therapeutics Corp. (KTTA), bought 311,546 shares at $1.21 ($377K) on 2022-08-17, disclosed to the SEC on 2022-08-18.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $1.21 | 155,773 | $188K | 50.0% |
| 2 | $1.21 | 155,773 | $188K | 50.0% |
| Total | $1.21 avg | 311,546 | $377K | 100% |
| Filing → |
| ABCP | SELL | 2024-02-20 | $1.4M | — | Filing → |
| ABCP | SELL | 2023-10-11 | $8K | — | Filing → |
| ABCP | SELL | 2023-09-26 | $11K | — | Filing → |